Several additional studies have similarly reported comparable findings, indicating that BT2 improves pathological remodeling and insulin sensitivity in failing hearts [115,116] and mitigates the adverse effects of 3-mercaptopyruvate sulfurtransferase (3-MST) deficiency on heart failure with a reduced ejection fraction (HFrEF) [117]. This evidence concerns the gene MPST and heart failure.